Feasibility of home-based automated Parkinson's disease motor assessment

Journal of Neuroscience Methods

Volumn 203, Issue 1, 2012, Pages 152-156

  Mera, Thomas O ^a   Heldman, Dustin A ^a   Espay, Alberto J ^b,c,d   Payne, Megan ^b,c,d   Giuffrida, Joseph P ^a  

^a Cleveland Medical Devices Inc   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c Department of Neurology ^*  (United States)

^d Gardner Family Center for Parkinson's Disease and Movement Disorders   (United States)

Author keywords

Bradykinesia; Home monitoring; Motion sensors; Parkinson's disease; Patient compliance; Tremor

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; COMPUTER INPUT DEVICE; COMPUTER PROGRAM; COMPUTER SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HOME MONITORING; HUMAN; IDIOPATHIC DISEASE; MALE; MOTION ANALYSIS SYSTEM; MOTOR PERFORMANCE; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCORING SYSTEM; SENSOR; TASK PERFORMANCE; TREMOR;

ALGORITHMS; ANTIPARKINSON AGENTS; COMPUTERS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MOTOR ACTIVITY; PARKINSON DISEASE; PATIENT COMPLIANCE; SOFTWARE;

EID: 81555214079     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.09.019     Document Type: Article

References (18)

1. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001, 16:448-458.
2. Chapuis S., Ouchchane L., Metz O., Gerbaud L., Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005, 20:224-230.
3. Costa J., Gonzalez H.A., Valldeoriola F., Gaig C., Tolosa E., Valls-Sole J. Nonlinear dynamic analysis of oscillatory repetitive movements in Parkinson's disease and essential tremor. Mov Disord 2010, 25:2577-2586.
4. Espay A., Giuffrida J., Chen R., Payne M., Mazzella F., Dunn E., Vaughan J., Duker A., Sahay A., Kim S., Revilla F., Heldman D. Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord 2011, 10.1002/mds.23893.
5. Fahn S. A new look at levodopa based on the ELLDOPA study. J Neural Transm Suppl 2006, 419-426.
6. Fahn S. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs later L-DOPA. Arch Neurol 1999, 56:529-535.
7. Giuffrida J.P., Riley D.E., Maddux B.N., Heldman D.A. Clinically deployable Kinesia technology for automated tremor assessment. Mov Disord 2009, 24:723-730.
8. Goetz C.G., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stebbins G.T., et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007, 22:41-47.
9. Heldman D.A., Giuffrida J.P., Chen R., Payne M., Mazzella F., Duker A.P., et al. The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures. Mov Disord 2011, 26:1859-1863.
10. Koller W.C., Vetere-Overfield B., Barter R. Tremors in early Parkinson's disease. Clin Neuropharmacol 1989, 12:293-297.
11. Lemstra A.W., Verhagen Metman L., Lee J.I., Dougherty P.M., Lenz F.A. Tremor-frequency (3-6Hz) activity in the sensorimotor arm representation of the internal segment of the globus pallidus in patients with Parkinson's disease. Neurosci Lett 1999, 267:129-132.
12. Manson A.J., Brown P., O'Sullivan J.D., Asselman P., Buckwell D., Lees A.J. An ambulatory dyskinesia monitor. J Neurol Neurosurg Psychiatry 2000, 68:196-201.
13. Patel S., Lorincz K., Hughes R., Huggins N., Growdon J., Standaert D., et al. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed 2009, 13:864-873.
14. Raethjen J., Pohle S., Govindan R.B., Morsnowski A., Wenzelburger R., Deuschl G. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response. Exp Neurol 2005, 194:151-160.
15. Rahimi F., Almeida Q.J., Wang D., Janabi-Sharifi F. Tremor suppression orthoses for parkinson's patients: a frequency range perspective. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:1565-1568.
16. Rigas G., Tzallas A.T., Tsalikakis D.G., Konitsiotis S., Fotiadis D.I. Real-time quantification of resting tremor in the Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:1306-1309.
17. Schrag A., Schelosky L., Scholz U., Poewe W. Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges. Mov Disord 1999, 14:252-255.
18. Weiss A., Herman T., Plotnik M., Brozgol M., Maidan I., Giladi N., et al. Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease?. Med Eng Phys 2010, 32:119-125.